FAQs | Site Map | Links | Home
January 13, 2009
skip navigation

  arrow Bill Tracking

  (spacer) Legislative Updates

  (spacer) Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Bill TrackingBill Tracking
(spacer)

House Bills - 110th Congress

Session I | arrow indicating current page Session II

H. R. 3689 —The Ovarian Cancer Biomarker Research Act of 2007

On September 27, 2007, Representative Howard Berman (D-CA) introduced H.R. 3689, the Ovarian Cancer Biomarker Research Act of 2007. The Senate companion, S. 1734, was introduced by Senator Barbara Boxer (D-CA) on June 28, 2007. The bill would amend Title IV of the PHS Act to require NCI to make awards for the establishment of centers to conduct research on biomarkers for ovarian cancer. The bill also requires the establishment of the Ovarian Cancer Biomarker Clinical Trial Committee to assist in the design and implementation of one or more national clinical trials to determine the utility of using biomarkers validated as a result of the research conducted by the centers. H.R. 3689 was referred to the House Committee on Energy and Commerce.

Legislative Update (March 2008): Ovarian Cancer Biomarker Act

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy